US ▾
WLY
Earnings call · Jul 2026 (Q1 FY27)

JOHN WILEY & SONS Q1 FY27 earnings call WLY

Sep 3, 2026 Source

Executive summary

John Wiley & Sons, Inc. Q1 FY27 — Strong Research & AI Momentum Offset by Prior Year AI Comparison and Learning Headwinds

Wiley's Q1 FY27 performance aligned with expectations, as robust growth in its Research and AI segments was tempered by a challenging prior-year AI licensing comparison and continued softness in the Learning division. The company is building on its momentum from the previous fiscal year, focusing on scaling new revenue streams and leveraging its content for AI and data analytics. Management reaffirmed its full-year outlook, anticipating a stronger performance in later quarters as market conditions normalize and new initiatives gain traction.

Highlights

5

  • Research publishing increased by 12% due to strong demand and the Emerald acquisition.

  • AI revenue reached $14 million in Q1, ahead of the pace needed for full-year targets, with $10.5 million from model training and $3.5 million recurring.

  • Research adjusted EBITDA margin expanded by 130 basis points to 29.6% driven by Emerald and cost savings.

  • Corporate expenses on an adjusted EBITDA basis decreased by 19% or $8 million.

  • Dividend raised for the 33rd consecutive year.

Concerns

5

  • Total revenue was impacted by a $29 million prior year AI licensing comparison.

  • Learning segment revenue declined by 20% to $93 million due to soft market conditions in professional and academic.

  • Adjusted EBITDA was down 4% year-over-year.

  • Adjusted EPS was down 10% due to higher net interest expense from the Emerald acquisition.

  • GAAP EPS was a loss of $0.23, compared to earnings of $0.22 in the prior year, largely due to restructuring and acquisition costs.

Guidance & targets

CategoryTargetConfidence
Full-year Organic Revenue Growth
low to mid-single digits
high materiality
High
Full-year Research Organic Growth
mid-single digits
medium materiality
High
Full-year Adjusted EBITDA Margin
26.5% to 27.5%
high materiality
High
Full-year Adjusted EPS
$4.60 to $5.05
high materiality
High
Full-year Free Cash Flow
$205 million
high materiality
High
Full-year CapEx
approximately $80 million
medium materiality
High
Emerald EPS Accretion
accretive in year 1
medium materiality
High
Emerald Cost Synergies
$30 million by year 3
medium materiality
High
AI Revenue
over $50 million
high materiality
High
AI Recurring Revenue Growth
2 to 3x over prior year
medium materiality
High

Segment performance

SegmentRevenueYoYQoQMargin
Research
Strong performance driven by Open Access growth, AI licensing, and the Emerald acquisition. Research solutions declined due to prior year AI licensing comparison and softer publishing services. Margin expansion was due to Emerald and organic cost savings.
Publishing growth: 12%Emerald contribution to publishing: $13 millionPublishing growth excluding Emerald: 6%Research solutions decline: 30%Adjusted EBITDA margin: 29.6%Emerald contribution to Adjusted EBITDA: $5 millionSubmissions up: 31%Output up: 8%Customer retention: above 99%Journals migrated to Research Exchange: 1,600Clinical outcome assessments revenue (FY26): $11 millionClinical outcome assessments revenue (FY25): $6 million
$293 million4%—Adjusted EBITDA: $87 million
Learning
Revenue decline primarily due to prior year AI licensing comparison and soft market conditions in professional (retail and corporate demand) and academic. Q1 is seasonally the smallest period for Learning. Inclusive Access and courseware continue to grow.
Academic revenue: $45 millionAcademic revenue decline: 20%Prior year AI licensing in Academic: $8 millionProfessional revenue: $48 millionProfessional revenue decline: 20%Prior year AI licensing in Professional: $5 millionSegment decline excluding prior year AI comparison: just under 10%Adjusted EBITDA margin: 15.1%Prior year Adjusted EBITDA margin: 27.4%
$93 million-20%—Adjusted EBITDA: $14 million

WLY operating KPIs by quarter

WLY operating KPIs stated on its earnings calls, by fiscal quarter
KPI Apr 2026 Q4 FY26This call Jul 2026 Q1 FY27Change vs prior quarter
AI subscription knowledge feeds corporate customers
19 We now count 19 corporate customers for AI subscription knowledge feeds, up from 10 last quarter. Source transcript
23 On the corporate side, we've expanded our customer base for subscription knowledge feeds, bringing us to 23 across 5 industry verticals: life sciences, health care, food and agriculture, materials and chemistry and financial services. Source transcript
+21.1%
Nexus AI publisher partners
41 Our Nexus AI licensing service now consists of 41 publisher partners from top-tier societies to multidisciplinary publishers. Source transcript
71 Finally, our Nexus licensing service continues to add more society and publishing partners, bringing the total to 71. Source transcript
+73.2%

Operating figures the company states on every call, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Product announcements

ProductTypeDetails
Spectral Analysis API Portfoliolaunch
Advanced Immunology journallaunch
Advanced Brain journallaunch

Deals & partnerships

Emerald Publishing Acquisition of a publishing company to extend scale advantage in research and content for AI and data analytics. approximately $450 million net in cash

Integration is ahead of schedule, with cost synergy capture underway and early AI licensing interest building. Culturally and strategically a strong fit.

U.S. Department of Energy (Genesis Mission) Participation in a public-private partnership focused on applying AI to science and technology problems.

Wiley is the sole scientific publisher involved. Role includes making research intelligence tools available to DOE National Laboratories, providing thought leadership on AI model validation and scientific data management, and helping shape the consortium's foundational knowledge layer. Builds on decades of engagement with federal science agencies.

CuspAI Founding data partner for CuspAI's Global Materials Foundry, aimed at speeding up new materials discovery.

The foundry focuses on semiconductors, clean energy, and advanced manufacturing. Wiley's contribution is the data layer, licensing access to its material science content to train the CuspAI platform. Underscores how Wiley's content is integrated into AI systems driving scientific discovery.

IQVIA Go-to-market partnership for clinical outcome assessments.

Leverages IQVIA's presence in drug evaluation and clinical trials with Wiley's peer-reviewed clinical outcome assessment instruments. Partnership is scaling and activating new in-demand instruments.

OpenEvidence Partnership for medical content delivery. $15 million 5 years

Partnership is deepening with additional content now under agreement. OpenEvidence has a strong footprint into the U.S. physician market, allowing Wiley to leverage its content for new revenue streams.

Anthropic Collaboration on technical integrations for AI, including citation and attribution requirements.

Part of Wiley's commitment to responsible AI, ensuring intellectual property protection and integrity standards for content use in AI models.

Risks & headwinds

Prior year AI licensing comparison Q1 FY27

$29 million

Mitigation:Focus on growing continuous AI revenue streams and strong pipeline for future quarters.

Soft market conditions in Learning segment Q1 FY27

Learning revenue down 20%

Mitigation:Concentrating editorial list, pushing digital and Inclusive Access, taking cost out to protect margin. Expects retail channel inventories to normalize and assessments to improve.

Higher net interest expense Q1 FY27

Impacted Adjusted EPS down 10%

Mitigation:Related to Emerald acquisition financing; pro forma leverage is within target range.

Restructuring charges and acquisition/integration costs Q1 FY27

GAAP EPS loss of $0.23 vs. earnings of $0.22 prior year

Mitigation:These are one-time costs associated with strategic initiatives like technology transformation and the Emerald acquisition, expected to yield future benefits.

Retail channel inventory reduction (Amazon) Q1 FY27, started late August prior year

Industry unit sales declined at the same rate as ours

Mitigation:Management is monitoring and thinking about title positioning, managing through the impact. Expects normalizing trends.

What to watch in Q2 FY27

AI licensing revenue realization

Q2 and Q3 FY27
Current $14 million in Q1 FY27
Target Realization of additional $14 million contracted for Q2 and Q3 FY27

Why it matters

This will indicate the pace of AI revenue growth and the company's ability to meet its full-year AI revenue target of over $50 million, which is a key growth engine.

As I mentioned, we've contracted a further $14 million of AI licensing revenue that will be realized across Q2 and Q3, with additional agreements in active discussion.

Q&A highlights

How does Research's 5% organic growth (excluding AI and Emerald) compare to peers and what drives confidence in the mid-single-digit outlook?

Management stated their growth is in line with market leaders, which they estimate at 3-4% long-term. Confidence is driven by strong KPIs, robust publishing pipeline, successful renewal season, double-digit Open Access growth, and investments in advanced brands and geographic expansion. They expect momentum to build throughout the year.

“We're growing along the same lines with the leaders in the market. And the confidence is really driven by many of the leading indicators that I talked about. Our KPIs are quite strong.”

asked by Unknown Analyst · answered by Matthew Kissner

3 min read 5 chapters

Detailed narrative

AI and Data Analytics Momentum

Wiley is rapidly advancing its AI and data analytics growth engine, with Q1 AI revenue reaching $14 million, ahead of the pace for the full-year target of over $50 million. This includes $10.5 million from model training and $3.5 million from recurring revenue. The company has already contracted an additional $14 million in AI licensing revenue for Q2 and Q3. Wiley's strategy involves leveraging its extensive content portfolio, including 150+ therapeutic areas and 100+ chemistry areas, to fuel AI systems for scientific discovery and R&D. Partnerships with entities like the U.S. Department of Energy's Genesis Mission and CuspAI's Global Materials Foundry highlight Wiley's role as a foundational data partner for AI innovators.

Research Segment Strength and Emerald Integration

The Research segment demonstrated strong performance with publishing throughput increasing by 12%, driven by robust global demand, record submissions (up 31%), and the Emerald acquisition. Customer retention remained above 99% in the calendar 2026 general renewal season. The integration of Emerald Publishing, acquired for approximately $450 million, is ahead of schedule, contributing $13 million to revenue and $5 million to adjusted EBITDA in Q1. Management expects Emerald to be EPS accretive in year 1 and achieve $30 million in cost synergies by year 3, reinforcing Wiley's scale advantage and content for AI.

Learning Segment Challenges and Outlook

The Learning segment faced significant headwinds in Q1, with revenue down 20% to $93 million. This decline was primarily due to a $13 million prior-year AI licensing comparison and soft market conditions, particularly in professional publishing and retail. Academic learning, however, showed health in digital content, courseware, and Inclusive Access. Management expects retail channel inventories to normalize and assessments to improve throughout the year, with a focus on optimizing the editorial list, pushing digital content, and implementing cost-saving initiatives to protect margins.

Capital Allocation and Financial Position

Wiley continues its disciplined capital allocation strategy, focusing on organic investment in journal expansion, clinical outcome assessments, and AI platforms, with CapEx expected to increase to $80 million for FY27. The Emerald acquisition was a key inorganic investment. The company returned $33 million to shareholders through dividends and repurchases, marking its 33rd consecutive year of dividend increases. Free cash flow improved by $30 million year-over-year, though it remained a use of $70 million in Q1, consistent with seasonal patterns. Net debt to EBITDA stood at 2.7x, or 2.1x pro forma for Emerald synergies, within the target range of 1.5x to 2.5x.

Responsible AI and Thought Leadership

Wiley is positioning itself as a leader in responsible AI, emphasizing human oversight, trust, transparency, safety, fairness, and good governance. The company's approach focuses on the quality of knowledge fueling AI models, rather than just model-outward policies. This includes comprehensive AI guidelines for authors, editors, and peer reviewers, and direct integration of citation and attribution requirements. Wiley's participation in the United Nations AI for Good Global Summit and partnerships like the DOE's Genesis Mission underscore its role in setting the agenda for ethical and evidence-based AI development.

AI-generated summary of the company's earnings call. Not investment advice.